Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis.

MLA

Świerczek, Artur, et al. “Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis.” The Journal of Pharmacology and Experimental Therapeutics, vol. 381, no. 2, May 2022, pp. 151–63. EBSCOhost, https://doi.org/10.1124/jpet.121.001004.

APA

Świerczek, A., Pomierny, B., Wyska, E., & Jusko, W. J. (2022). Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis. The Journal of Pharmacology and Experimental Therapeutics, 381(2), 151–163. https://doi.org/10.1124/jpet.121.001004

Chicago

Świerczek, Artur, Bartosz Pomierny, Elżbieta Wyska, and William J Jusko. 2022. “Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis.” The Journal of Pharmacology and Experimental Therapeutics 381 (2): 151–63. doi:10.1124/jpet.121.001004.